New York State Department of Health
Phosphorus Wins Conditional New York State Approval for GeneCompass Consumer Test
The firm's health screening sequencing assay, which retails at $249 and covers a panel of over 400 genes, will now be available to consumers in all 50 states.
Grail Gets NY State Department of Health Approval for Galleri Multicancer Test
Galleri is designed to detect more than 50 cancer types through a routine blood draw and, when a cancer signal is detected, predict its origin.
Castle Biosciences Receives New York State Approval for DecisionDx DiffDx-Melanoma Test
The gene expression profile assay is meant to aid dermatopathologists in characterizing difficult-to-diagnose melanocytic lesions.
Karius Receives NY State Approval for Infectious Disease Liquid Biopsy Test
The permit covers the test for all five pathogen categories: bacteriology, mycobacteriology, mycology, parasitology, and virology.
Castle Biosciences Receives NYS DOH Approval for Skin Cancer Diagnostic
The company's DecisionDx-SCC is meant to predict risk of cutaneous squamous cell carcinoma metastasis for patients with one or more risk factors.